Oscar Health Inc reports results for the quarter ended June 30 - Earnings Summary

• Oscar Health Inc OSCR.N reported a quarterly adjusted loss of 89 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 20 cents. The mean expectation of nine analysts for the quarter was for a loss of 46 cents per share. Wall Street expected results to range from -90 cents to 23 cents per share.

• Revenue rose 29% to $2.86 billion from a year ago; analysts expected $2.89 billion.

• Oscar Health Inc's reported EPS for the quarter was a loss of 89 cents​.

• The company reported a quarterly loss of $228.36 million.

• Oscar Health Inc shares had fallen by 35.5% this quarter and gained 2.8% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 212.1% in the last three months.​

• In the last 30 days, six analysts negatively revised earnings estimates

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 2 "strong buy" or "buy," 3 "hold" and 5 "sell" or "strong sell." The average consensus recommendation for the life & health insurance peer group is "buy."

• Wall Street's median 12-month price target for Oscar Health Inc is $11.00, about 25.6% below its last closing price of $13.82

This summary was machine generated from LSEG data August 6 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)